Glucose phosphate isomerase (GPI) Tadikonda: Characterization of a novel Pro340Ser mutation.

Abstract

After a thirty-year lag, we serendipitously reestablished contact with a patient with glucose phosphate isomerase deficiency and hydrops fetalis first reported in 1987. We now provide a clinical update and provide results of mutation analysis in this patient, from Southern India. The patient now an adult female of 36 years of age has moderate anemia but requires no transfusions except with some intercurrent illnesses. Exome sequencing studies showed a homozygous c.1018C>T (Pro340Ser) mutation in exon 12 of the glucose phosphate isomerase gene and later confirmed by direct sequencing. This mutation has not been previously described. To our knowledge, this is also the first known homozygous mutation in the hydrophobic core of the protein and is a highly deleterious mutation by in silico analysis and by clinical history in the family. Flow cytometry studies of band 3 content with eosin maleimide showed a unique tail of red cells on histograms, reflecting the dense red cells (presumably ATP depleted) seen on blood smears; similar findings were seen in patients with pyruvate kinase and phosphoglycerate kinase deficiency.

• Authors: Ahmar U Zaidi, Prabhakar Kedar, Prasad Rao Koduri, Gerard W Goyette Jr, Steven Buck, Donald E Paglia, Yaddanapudi Ravindranath
• Journal: Pediatric hematology and oncology (Pediatr Hematol Oncol) Vol. 34 Issue 8 Pg. 449-454 (Nov 2017) ISSN: 1521-0669 [Electronic] England
• PMID: 29227722 (Publication Type: Case Reports, Journal Article)

Chemical References

• Cytokines
• GPI protein, human
• Glucose-6-Phosphate Isomerase

Topics

• Amino Acid Substitution
• Anemia (blood, genetics, therapy)
• Cytokines (deficiency)
• Female
• Glucose-6-Phosphate Isomerase
• Homozygote
• Humans
• Hydrops Fetalis (blood, genetics)
• Mutation, Missense